The Analyst Landscape: 17 Takes On Tenet Healthcare
Portfolio Pulse from Benzinga Insights
Analysts have provided mixed ratings for Tenet Healthcare (NYSE:THC) over the past three months, with a majority being somewhat bullish. The average 12-month price target has increased by 15.44% to $141.06. Tenet Healthcare has shown positive financial performance with strong revenue growth, net margin, ROE, and ROA, while maintaining a healthy debt-to-equity ratio.
July 25, 2024 | 3:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Analysts have mixed but mostly bullish ratings for Tenet Healthcare, with a significant increase in the average 12-month price target. The company's strong financial performance and healthy debt management are positive indicators.
The majority of analysts have a somewhat bullish outlook on Tenet Healthcare, with a notable increase in the average price target. The company's strong financial metrics, including revenue growth, net margin, ROE, and ROA, along with a healthy debt-to-equity ratio, support a positive short-term impact on the stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100